π― PSA Density Calculator
PSA interpreted against gland size.
For informational purposes only, not medical advice. Consult a healthcare professional.
PSA density divides the PSA level by the prostate volume, correcting for the fact that big benign glands make more PSA. A PSA of 5 in a 60 cc gland is expected; the same 5 in a 25 cc gland is not. Studies consistently show density predicts biopsy results better than PSA alone, and the widely used threshold is 0.15 ng/mL/cc: below it, cancer risk is lower; at or above it, evaluation is usually recommended. This calculator computes it for discussion with your urologist.
How to Use This Calculator
Enter the PSA in ng/mL and the prostate volume in cc from ultrasound or MRI. The calculator divides the two and compares with the 0.15 threshold.
Use a PSA drawn without recent confounders: no ejaculation, bike riding, or prostate manipulation for 48 hours, and no active urinary infection.
Enter the prostate volume in cc. If you only have ultrasound dimensions, run them through our prostate volume calculator first.
Read the density. Under 0.15 is reassuring; 0.15 and above raises the conversation about MRI or biopsy with your urologist.
How the Math Works
Divide PSA in ng/mL by prostate volume in cc. A PSA of 5.2 with a 45 cc gland gives 0.116, under the threshold. The 0.15 cutoff comes from studies showing it balances sensitivity and specificity better than PSA cutoffs alone, and it appears in guidelines as a trigger for further evaluation. Some analyses use 0.10 as a stricter line and 0.20 in already-biopsied men, but 0.15 remains the reference most clinicians quote. Density does not diagnose cancer; it sharpens the biopsy decision.
Worked Example
A PSA of 5.2 ng/mL with a 45 cc prostate gives a PSA density of 0.116 ng/mL/cc, which the calculator places in the Borderline band. The raw PSA of 5.2 sits above the traditional 4.0 flag, but the density tells the calmer story: much of that PSA is explained by gland size. The same PSA in a 25 cc gland would give 0.21 and a very different conversation.
Reading Your Result
Under 0.10 is reassuring in most contexts. The 0.10 to 0.15 band is a gray zone where trends and MRI findings carry weight. At 0.15 and above, guidelines generally favor prostate MRI and discussion of biopsy. Rising density on serial measurements worries more than a stable one, since stable benign growth raises both PSA and volume together while cancer raises PSA disproportionately.
| PSA density | Band | Typical next step |
|---|---|---|
| Under 0.10 | Low | Routine monitoring |
| 0.10-0.15 | Borderline | Watch trend, consider MRI |
| 0.15+ | Elevated | MRI and biopsy discussion |
Limitations
Density is only as good as the volume measurement, and ultrasound volumes vary between operators. It does not detect all cancers: some significant cancers hide under low density. PSA itself fluctuates with infection, instrumentation, and lab variation, so confirm an unexpected value before acting. Biopsy decisions integrate density with MRI, family history, and prior biopsies.
Related Calculators
Related tools: prostate volume calculator PSA doubling time calculator BMI calculator.
For informational purposes only, not medical advice. Consult a healthcare professional.
Frequently Asked Questions
What is PSA density?
PSA divided by prostate volume: how much PSA each cubic centimeter of gland produces. It adjusts for benign enlargement, which raises PSA innocently. A high density means the PSA is disproportionate to the gland size, which raises suspicion.
What is a normal PSA density?
Under 0.15 ng/mL/cc is the widely used reassuring range, with under 0.10 even more so. At 0.15 and above, evaluation with MRI and possible biopsy is generally recommended. These are decision aids, not diagnoses.
Why is 0.15 the cutoff?
It emerged from studies as the value balancing missed cancers against unnecessary biopsies better than PSA alone. Guidelines reference it as a biopsy trigger. Some clinicians use 0.10 for extra caution or 0.20 in men with prior negative biopsies.
Is PSA density better than PSA alone?
For the biopsy decision, yes in most studies: it consistently outperforms raw PSA at predicting significant cancer. PSA screening still starts the conversation, but density refines it. Combining density with MRI findings performs better still.
Can I lower my PSA density?
Treating benign enlargement shrinks volume and can lower PSA, but manipulating the number is not the goal. Finasteride roughly halves PSA, which complicates interpretation and must be disclosed. The density is a measurement to interpret, not a score to game.
Does a low density rule out cancer?
No. Most cancers are found at low densities simply because most men have low densities, and some aggressive cancers produce little PSA. It lowers the probability; it does not eliminate it. MRI adds the anatomical view density lacks.
How accurate is the volume measurement?
Ultrasound ellipsoid volumes typically run within 10 to 20 percent of true volume, with operator variation. MRI planimetry is more precise. Since density divides by volume, a 20 percent volume error moves the density 20 percent, so borderline results deserve remeasurement.
Should PSA be adjusted for finasteride?
Yes, and tell every clinician. Finasteride and dutasteride roughly halve PSA after months of use, so the true value is about double the lab number. Density calculated on the unadjusted number misleads.
What raises PSA besides cancer?
Benign enlargement, prostatitis, urinary infection, recent ejaculation, vigorous bike riding, prostate biopsy or catheterization, and even a vigorous rectal exam. Repeat the test after avoiding confounders before drawing conclusions from one value.
How often should PSA be checked?
Guidelines generally suggest discussing screening from 50, or 45 with risk factors like family history or African ancestry, with intervals of 1 to 2 years depending on the level and trend. It is a shared decision with your clinician, not a reflex annual test for everyone.